This Scientific Program aims to carry out biotechnology research projects and develop products that are transferable to industry from an applied systems biology perspective (sometimes called industrial systems biology) and synthetic biology.
These approaches are seen as the natural extension of modern biotechnology and metabolic engineering in the post-genomic era, thanks to the development of computational tools that provide models of genome-scale metabolic networks, as well as to the ease of chemical synthesis of DNA, greatly facilitating experimental work.
Therefore, methodologies encompass both modeling and experimental approaches in model organisms that are of biotechnological interest, at both laboratory and pilot-plant scale. In fact, this program converges with the strategic objectives of Biopolis S.L., a leading biotech company in the sector already synergistically involved in scientific collaboration with some of the founder research groups and whose presence will boost new joint projects in the area of metabolic engineering.
